London’s FDI Offers Help To Mid-Size Indian Drug Makers, Biotechs
This article was originally published in PharmAsia News
Executive Summary
London's foreign direct investment agency is looking at medium-size drug makers as possible targets for assisting in expanding their plans in Europe. Think London already is in negotiations with five unidentified Indian firms, offering help with agreements between them and 100 London-based drug makers and biotechs. The union is designed to help the Indian firms get market access to local regulatory agencies in Europe. Past clients in India include Arch Pharma, Aurobindo Pharma and Intas Pharmaceutical. (Click here for more
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.